A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Arcadia Biosciences, Inc.
RKDA
$875K
Mkt Cap
$0.64
+2.89%
Arcadia Biosciences, Inc. (RKDA) has a 5-year average return on invested capital (ROIC) of -88.4%. This is below average and may indicate limited pricing power.
Arcadia Biosciences, Inc. (RKDA) has a market capitalization of $875K. It is classified as a small-cap stock.
Arcadia Biosciences, Inc. (RKDA) does not currently pay a regular dividend.
Arcadia Biosciences, Inc. (RKDA) operates in the Crude Petroleum & Natural Gas industry, within the Energy sector.
Arcadia Biosciences, Inc. (RKDA) reported annual revenue of $5 million in its most recent fiscal year, based on SEC EDGAR filings.
Arcadia Biosciences, Inc. (RKDA) has a net profit margin of -48.1%. The company is currently unprofitable.
Arcadia Biosciences, Inc. (RKDA) generated $-5 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Prior to its transfer and sale during 2024 of the various assets described below, Arcadia was a producer and marketer of innovative, plant-based products. Arcadia sought to be a leader in science-based approaches to developing high value crop improvements, primarily in wheat which it commercialized through the sales of seed, grain, food ingredients and products, and through trait licensing and royalty agreements. The acquisition of the assets of Live Zola, LLC (“Zola”) in May 2021 added coconut water to Arcadia’s portfolio of products. In May 2021, Arcadia’s wholly owned subsidiary Arcadia Wellness, LLC (“Arcadia Wellness”), acquired the businesses of Eko Holdings, LLC, Lief, LLC.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 4.9M | 4.9M | 5.0M | - | 7.4M | 6.8M |
| Net Income | -2.3M | -2.3M | -7.0M | -14M | - | - |
| EPS | $-1.71 | $-1.71 | $-5.17 | $-11.29 | $-743.85 | $-799.24 |
| Free Cash Flow | -4.7M | -4.7M | -9.6M | -15M | -14M | -27M |
| ROIC | -50.9% | -47.7% | -134.9% | -82.5% | - | - |
| Gross Margin | 36.2% | 36.2% | 41.3% | - | 17.8% | -128.3% |
| Debt/Equity | 0.00 | 0.58 | 0.02 | 0.08 | 0.10 | 0.17 |
| Dividends/Share | $0.00 | $0.00 | - | - | - | - |
| Operating Income | -2.5M | -2.5M | -3.6M | -6.1M | -14M | -36M |
| Operating Margin | -51.5% | -51.5% | -72.3% | - | -188.8% | -524.0% |
| ROE | -56.5% | -45.1% | -73.8% | -82.5% | - | - |
| Shares Outstanding | 1M | 1M | 1M | 1M | 0M | 0M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | 8.0M | 6.8M | 7.4M | N/A | 5.0M | 4.9M | 4.9M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | 35.3% | -128.3% | 17.8% | N/A | 41.3% | 36.2% | 36.2% |
| R&D | 10M | 9.0M | 8.7M | 7.4M | 6.1M | 7.1M | 8.0M | 3.9M | 1.5M | 64K | 53K | 9K | 9K |
| SG&A | 10M | 11M | 12M | 11M | 12M | 14M | 16M | 23M | 15M | 8.2M | 9.6M | 7.0M | 7.0M |
| EBIT | -15M | -16M | -19M | -14M | -17M | -19M | -13M | -36M | -14M | -6.1M | -3.6M | -2.5M | -2.5M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | N/A | -159.0% | -524.0% | -188.8% | N/A | -72.3% | -51.5% | -51.5% |
| Net Income | -22M | -21M | -20M | -16M | -13M | -29M | -4.7M | N/A | N/A | -14M | -7.0M | -2.3M | -2.3M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | -57.9% | N/A | N/A | N/A | -139.5% | -48.1% | -48.1% |
| Non-Recurring | -3K | 10K | -4K | 1K | 3K | -3K | 8K | 1.6M | 314K | 40K | 101K | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | -60.9% | -21.0% | -34.9% | -56.8% | -129.5% | -47.0% | -24.7% | N/A | N/A | -82.5% | -134.9% | -47.7% | -50.9% |
| ROE | 43.3% | 93.1% | -62.9% | -104.0% | -129.5% | -280.8% | -26.3% | N/A | N/A | -82.5% | -73.8% | -45.1% | -56.5% |
| ROA | -88.7% | -41.8% | -30.0% | -42.9% | -66.4% | -101.8% | -11.6% | N/A | N/A | -57.5% | -42.4% | -23.3% | -35.7% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -15M | -15M | -17M | -14M | -14M | -17M | -30M | -26M | -14M | -15M | -9.6M | -4.7M | -4.7M |
| Free Cash Flow | -15M | -15M | -17M | -14M | -14M | -19M | -33M | -27M | -14M | -15M | -9.6M | -4.7M | -4.7M |
| Owner Earnings | -16M | -17M | -18M | -16M | -15M | -20M | -33M | -28M | -16M | -16M | -10M | -5.0M | -5.0M |
| CapEx | 148K | 151K | 231K | 79K | 250K | 1.5M | 2.3M | 1.0M | 72K | 5K | 16K | 0 | 0 |
| Maint. CapEx | 358K | 294K | 304K | 279K | 154K | 194K | 662K | 1.0M | 479K | 111K | 58K | 32K | 32K |
| Growth CapEx | 0 | 0 | 0 | 0 | 96K | 1.3M | 1.7M | 0 | 0 | 0 | 0 | N/A | 0 |
| D&A | 358K | 294K | 304K | 279K | 154K | 194K | 662K | 1.0M | 479K | 111K | 58K | 32K | 32K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | 976K | 1.4M | 1.1M | 1.5M | 1.6M | 2.3M | 2.0M | 1.5M | 1.1M | 717K | 512K | 234K | 234K |
| Debt Repayment | 0 | 1.3M | 46K | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | -6.6M | -25M | -25M | 12M | -22M | -23M | -16M | -13M | -19M | -11M | -4.1M | N/A | -259K |
| Cash & Equiv. | 17M | 24M | 2.0M | 9.1M | 12M | 8.4M | 14M | 29M | 21M | 6.5M | 4.2M | 259K | 259K |
| Long-Term Debt | 8.9M | 25M | 25M | 0 | 0 | 107K | 2.1M | 0 | 0 | N/A | N/A | N/A | N/A |
| Debt/Equity | -0.12 | 0.62 | 1.13 | 3.12 | 0.00 | 0.29 | 0.34 | 0.17 | 0.10 | 0.08 | 0.02 | 0.58 | 0.00 |
| Interest Coverage | -10.9 | -5.9 | -14.1 | -19.2 | -6.6 | -3876.2 | -271.9 | -1776.3 | -48.5 | -8.8 | -4.7 | -11.3 | -11.3 |
| Equity | -85M | 40M | 22M | 8.0M | 13M | 7.7M | 28M | 31M | 21M | 13M | 6.2M | 4.1M | 4.1M |
| Total Assets | 25M | 74M | 57M | 17M | 24M | 33M | 47M | 44M | 29M | 20M | 14M | 6.5M | 6.5M |
| Total Liabilities | 110M | 34M | 34M | 8.6M | 11M | 24M | 19M | 13M | 8.0M | 7.0M | 7.3M | 2.4M | 2.4M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | 370K | 484K | 40K | 39K | 39K | 39K | 39K |
| Retained Earnings | -114M | -132M | -152M | -167M | -178M | -207M | -212M | -226M | -258M | -272M | -279M | -281M | -281M |
| Working Capital | 7.4M | 49M | 49M | 12M | 20M | 23M | 25M | 30M | 21M | 11M | 6.7M | 4.3M | 4.3M |
| Current Assets | 19M | 52M | 52M | 15M | 23M | 28M | 32M | 35M | 25M | 15M | 9.2M | 6.4M | 6.4M |
| Current Liabilities | 11M | 3.4M | 3.1M | 3.5M | 3.1M | 5.7M | 6.3M | 5.0M | 4.2M | 3.6M | 2.6M | 2.1M | 2.1M |
| Per Share Data | |||||||||||||
| EPS | -3,105.90 | -211.70 | -2,566.50 | -2,111.20 | -51.91 | -65.69 | -6.82 | -799.24 | -743.85 | -11.29 | -5.17 | -1.71 | -1.71 |
| Owner EPS | -2,267.98 | -171.54 | -2,408.77 | -2,112.68 | -59.05 | -44.87 | -48.20 | -1,487.83 | -732.53 | -13.02 | -7.49 | -3.66 | -3.66 |
| Book Value | -11,925.29 | 410.85 | 2,903.14 | 1,076.23 | 49.35 | 17.57 | 40.59 | 1,625.82 | 990.06 | 10.37 | 4.57 | 3.03 | 3.03 |
| Cash Flow/Share | -2,080.31 | -154.32 | -2,230.52 | -1,877.06 | -52.49 | -39.22 | -44.24 | -1,352.61 | -657.92 | -12.35 | -7.07 | -3.46 | -1.69 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 |
| Shares Out. | 0.0M | 0.1M | 0.0M | 0.0M | 0.3M | 0.4M | 0.7M | 0.0M | 0.0M | 1.2M | 1.4M | 1.4M | 1.4M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -0.4 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | 2.4 | 2.1 | 1.4 | 0.9 | 17.0 | 0.9 | 1.2 | 0.7 | 0.3 | 1.3 | N/A | 0.2 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | 4.6 | 12.4 | N/A | N/A | 0.8 | N/A | 0.2 |
| FCF Yield | N/A | -15.8% | -37.1% | -124.7% | -122.5% | -14.3% | -129.4% | -72.5% | -98.4% | -363.4% | -115.9% | N/A | -541.3% |
| Market Cap | N/A | 97M | 47M | 11M | 11M | 131M | 25M | 37M | 14M | 4.2M | 8.3M | 0 | 875K |
| Avg. Price | N/A | 3,983.69 | 1,690.21 | 469.25 | 353.79 | 202.78 | 147.74 | 98.13 | 35.75 | 5.84 | 3.01 | 0.00 | 0.64 |
| Year-End Price | N/A | 2,720.00 | 840.00 | 208.80 | 120.40 | 245.60 | 101.60 | 43.20 | 10.48 | 3.40 | 6.11 | 0.00 | 0.64 |
Arcadia Biosciences, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
Arcadia Biosciences, Inc. (RKDA) has a debt-to-equity ratio of 0.58. This indicates moderate leverage.
Arcadia Biosciences, Inc. (RKDA) reported earnings per share (EPS) of $-1.71 in its most recent fiscal year.
Arcadia Biosciences, Inc. (RKDA) has a return on equity (ROE) of -45.1%. A negative ROE may indicate losses or negative equity.
Arcadia Biosciences, Inc. (RKDA) has a 5-year average gross margin of -8.3%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 12 years of financial data for Arcadia Biosciences, Inc. (RKDA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Arcadia Biosciences, Inc. (RKDA) has a book value per share of $3.03, based on its most recent annual SEC filing.